Systematic review: Medical and nutritional interventions for the management of intestinal failure and its resultant complications in children

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 2, 2011, Pages 175-184

  Barclay, A R ^a,b   Beattie, L M ^b   Weaver, L T ^b   Wilson, D C ^a,c  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHOLECYSTOKININ; EPIDERMAL GROWTH FACTOR; FISH OIL; GLUTAMINE; GROWTH HORMONE; INTRALIPID; METRONIDAZOLE; PROBIOTIC AGENT; SOMATOMEDIN; SOMATOSTATIN DERIVATIVE; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID; WARFARIN;

ARTICLE; CHILD; CHILD HEALTH CARE; CINAHL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCHRANE LIBRARY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENTERIC FEEDING; ENTEROPATHY; EVIDENCE BASED MEDICINE; HUMAN; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTESTINE ADAPTATION; INTESTINE FAILURE; INTESTINE FUNCTION; LIVER DISEASE; MEDLINE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; SYSTEMATIC REVIEW; THROMBOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENTERAL NUTRITION; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INTESTINES; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 78650300753     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04514.x     Document Type: Article

References (87)

1. Goulet O, Ruemmele F, Lacaille F, Colomb V,. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004; 38: 250-69.
2. Gupte GL, Beath SV, Kelly DA, Millar AJ, Booth IW,. Current issues in the management of intestinal failure. Arch Dis Child 2006; 91: 259-64.
3. Nightingale JM,. Management of patients with a short bowel. Nutrition 1999; 15: 633-7.
4. Goulet O,. Intestinal failure in children. Transplant Proc 1998; 30: 2523-5.
5. Goulet O, Ruemmele F,. Causes and management of intestinal failure in children. Gastroenterology 2006; 130: S16-28. (Pubitemid 43208856)
6. Vanderhoof JA, Young RJ, Thompson JS,. New and emerging therapies for short bowel syndrome in children. Paediatr Drugs 2003; 5: 525-31.
7. Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997; 24: 102-12.
8. Goulet O, Kedinger M, Brousse N, et al. Intractable diarrhea of infancy with epithelial and basement membrane abnormalities. J Pediatr 1995; 127: 212-9.
9. Phillips AD, Jenkins P, Raafat F, Walker-Smith JA,. Congenital microvillous atrophy: specific diagnostic features. Arch Dis Child 1985; 60: 135-40.
10. Gupte GL, Beath SV, Protheroe S, et al. Improved outcome of referrals for intestinal transplantation in the UK. Arch Dis Child 2007; 92: 147-52.
11. Sacks AI, Warwick GJ, Barnard JA,. Early proliferative events following intestinal resection in the rat. J Pediatr Gastroenterol Nutr 1995; 21: 158-64.
12. Sukhotnik I, Siplovich L, Shiloni E, Mor-Vaknin N, Harmon CM, Coran AG,. Intestinal adaptation in short-bowel syndrome in infants and children: a collective review. Pediatr Surg Int 2002; 18: 258-63.
13. Goulet OJ, Revillon Y, Jan D, et al. Neonatal short bowel syndrome. J Pediatr 1991; 119: 18-23.
14. Kelly DA,. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006; 130: S70-7.
15. Barclay AR, Paxton CE, Gillett P, et al. Regionally acquired intestinal failure data suggest an underestimate in national service requirements. Arch Dis Child 2009; 94: 938-43.
16. Nightingale J, Woodward JM,. Guidelines for management of patients with a short bowel. Gut 2006; 55 (Suppl. 4): iv1-12.
17. Quigley EM, Quera R,. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130: S78-90.
18. Lloyd DA, Gabe SM,. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66: 530-8.
19. The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18-23.
20. Harbour R, Miller J,. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-6.
21. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R,. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41 (Suppl. 2): S1-87.
22. Allen SJ, Pierro A, Cope L, et al. Glutamine-supplemented parenteral nutrition in a child with short bowel syndrome. J Pediatr Gastroenterol Nutr 1993; 17: 329-32.
23. Bines J, Francis D, Hill D,. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998; 26: 123-8.
24. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH,. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr 2004; 145: 317-21.
25. Christie DL, Ament ME,. Dilute elemental diet and continuous infusion technique for management of short bowel syndrome. J Pediatr 1975; 87: 705-8.
26. Collier S, Crough J, Hendricks K, Caballero B,. Use of cyclic parenteral nutrition in infants less than 6 months of age. Nutr Clin Pract 1994; 9: 65-8.
27. De Marco G, Sordino D, Bruzzese E, et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 2006; 24: 387-94.
28. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW,. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009; 48: 209-15.
29. Finkel Y, Brown G, Smith HL, Buchanan E, Booth IW,. The effects of a pectin-supplemented elemental diet in a boy with short gut syndrome. Acta Paediatr Scand 1990; 79: 983-6.
30. Goulet O, De Potter S, Antebi H, et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 1999; 70: 338-45.
31. Gura K, Strijbosch R, Arnold S, McPherson C, Puder M,. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract 2007; 22: 664-72.
32. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118: e197-201.
33. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121: e678-86.
34. Heubi JE, Wiechmann DA, Creutzinger V, et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr 2002; 141: 237-42.
35. Kanamori Y, Hashizume K, Sugiyama M, Morotomi M, Yuki N,. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci 2001; 46: 2010-6.
36. Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R,. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 2004; 39: 1686-92.
37. Ksiazyk J, Piena M, Kierkus J, Lyszkowska M,. Hydrolyzed versus nonhydrolyzed protein diet in short bowel syndrome in children. J Pediatr Gastroenterol Nutr 2002; 35: 615-8.
38. Kubota A, Okada A, Imura K, et al. The effect of metronidazole on TPN-associated liver dysfunction in neonates. J Pediatr Surg 1990; 25: 618-21.
39. Ladd AP, Grosfeld JL, Pescovitz OH, Johnson NB,. The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome. J Pediatr Surg 2005; 40: 442-5.
40. Lee SI, Valim C, Johnston P, et al. The impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009; 66: 698-703.
41. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L,. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 1999; 12: 549-53.
42. MacMahon RA,. The use of the World Health Organization's oral rehydration solution in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr 1984; 8: 720-1.
43. Meehan JJ, Georgeson KE,. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 1997; 32: 473-5.
44. Mouw E, Chessman K, Lesher A, Tagge E,. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 2008; 43: 1025-9.
45. Newall F, Barnes C, Savoia H, Campbell J, Monagle P,. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics 2003; 112: e386.
46. Nucci AM, Finegold DN, Yaworski JA, Kowalski L, Barksdale EM Jr,. Results of growth trophic therapy in children with short bowel syndrome. J Pediatr Surg 2004; 39: 335-9.
47. Ohlbaum P, Galperine RI, Demarquez JL, Vergnes P, Martin C,. Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 1987; 6: 466-70.
48. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250: 395-402.
49. Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB,. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 2005; 40: 763-8.
50. Spagnuolo MI, Iorio R, Vegnente A, Guarino A,. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 1996; 111: 716-9.
51. Teitelbaum DH, Han-Markey T, Drongowski RA, et al. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 1997; 21: 100-3.
52. Thompson JM, Brett A, Rose SJ,. Dietary management of intestinal lymphangiectasia complicated by short gut syndrome. Hum Nutr Appl Nutr 1986; 40: 136-40.
53. Uchida K, Takahashi T, Inoue M, et al. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int 2007; 23: 243-8.
54. Vanderhoof JA, Young RJ, Murray N, Kaufman SS,. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998; 27: 155-60.
55. Donnell SC, Lloyd DA, Eaton S, Pierro A,. The metabolic response to intravenous medium-chain triglycerides in infants after surgery. J Pediatr 2002; 141: 689-94.
56. Mertes N, Grimm H, Furst P, Stehle P,. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006; 50: 253-9.
57. Flynn DM, Gowen H,. Paediatric parenteral nutrition and lipid usage in the UK-a pick N' mix situation? Clin Nutr 2010; 29: 275-6.
58. Inoue Y, Copeland EM, Souba WW,. Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 1994; 219: 715-22.
59. Shulman DI, Hu CS, Duckett G, Lavallee-Grey M,. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr 1992; 14: 3-11.
60. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW,. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243-54.
61. Jeppesen PB, Szkudlarek J, Hoy CE, Mortensen PB,. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol 2001; 36: 48-54.
62. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113: 1074-81.
63. Matarese LE, Seidner DL, Steiger E,. Growth hormone, glutamine, and modified diet for intestinal adaptation. J Am Diet Assoc 2004; 104: 1265-72.
64. Wales PW, Nasr A, De SN, Yamada J,. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 2010; 6: CD006321.
65. Scolapio JS,. Short bowel syndrome. JPEN J Parenter Enteral Nutr 2002; 26: S11-6.
66. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ,. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113: 884-90.
67. Cheng K, Ashby D, Smyth R,. Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev 2000; 2: CD000222.
68. San LV, Btaiche IF,. Ursodiol in patients with parenteral nutrition-associated cholestasis. Ann Pharmacother 2007; 41: 1867-72.
69. Grimble GK, Rees RG, Keohane PP, Cartwright T, Desreumaux M, Silk DB,. Effect of peptide chain length on absorption of egg protein hydrolysates in the normal human jejunum. Gastroenterology 1987; 92: 136-42.
70. Jeppesen PB, Mortensen PB,. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998; 43: 478-83.
71. Vanderhoof JA, Grandjean CJ, Kaufman SS, Burkley KT, Antonson DL,. Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr 1984; 8: 685-9.
72. Agostoni C, Axelsson I, Braegger C, et al. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004; 38: 365-74.
73. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-9.
74. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-14.
75. Szajewska H, Ruszczynski M, Radzikowski A,. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149: 367-72.
76. Barclay AR, Stenson B, Simpson JH, Weaver LT, Wilson DC,. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007; 45: 569-76.
77. Bradshaw JH, Puntis JW,. Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Pediatr Gastroenterol Nutr 2008; 47: 179-86.
78. Cowles RA, Ventura KA, Martinez M, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg 2010; 45: 84-7.
79. Diamond IR, De Silva N, Pencharz PB, Kim JH, Wales PW,. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg 2007; 42: 806-11.
80. Koehler AN, Yaworski JA, Gardner M, Kocoshis S, Reyes J, Barksdale EM Jr,. Coordinated interdisciplinary management of pediatric intestinal failure: a 2-year review. J Pediatr Surg 2000; 35: 380-5.
81. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009; 19: 348-53.
82. Torres C, Sudan D, Vanderhoof J, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007; 45: 204-12.
83. Sudan D,. Advances in the nontransplant medical and surgical management of intestinal failure. Curr Opin Organ Transplant 2009; 14: 274-9.
84. Dell-Olio D, Beath SV, De V, et al. Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr 2009; 48: 334-40.
85. Beath S,. Review of current management practices in intestinal failure associated liver disease. Available at:. Accessed November 2009.
86. Beattie RM, Puntis J,. The future of intestinal failure services in England and Wales; a report on behalf of BSPGHAN. Available at:. Accessed November 2009.
87. Diamond IR, Pencharz PB, Wales PW,. Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg 2009; 18: 239-45.